Neurocrine Bioscience buy Piper Sandler
Start price
06.05.25
/
50%
€105.90
Target price
06.05.26
€136.35
Performance (%)
3.82%
Price
10.04.26
€109.95
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler shows slight gains of 3.82%. This prediction currently runs until 06.05.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -3.637% | -3.637% |
| iShares Core DAX® | 2,55 % | 0,56 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % |
| iShares S&P 500 | 1,93 % | -0,51 % |
Comments by Piper_Sandler for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $154.00 price target on the stock, down previously from $160.00.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Piper_Sandler for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€153.67
29.10.26
29.10.26
-6.70%
10.04.26
10.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€115.25
31.07.25
31.07.25
€153.09
31.07.26
31.07.26
-4.60%
10.04.26
10.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€130.60
23.12.24
23.12.24
€153.97
23.12.25
23.12.25
-6.36%
24.12.25
24.12.25